Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice-Reference-Cited by-同舟云学术

Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice

Published:2009-03-18 Issue:6 Volume:85 Page:607-614
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Hebert MF,Ma X,Naraharisetti SB,Krudys KM,Umans JG,Hankins GDV,Caritis SN,Miodovnik M,Mattison DR,Unadkat JD,Kelly EJ,Blough D,Cobelli C,Ahmed MS,Snodgrass WR,Carr DB,Easterling TR,Vicini P

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference49 articles.

1. A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus

2. Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer

3. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes*

4. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-step vs 2-step gestational diabetes mellitus screening and pregnancy outcomes: an updated systematic review and meta-analysis;American Journal of Obstetrics & Gynecology MFM;2024-05

2. The impact of pregnancy and associated hormones on the pharmacokinetics of Δ ⁹ -tetrahydrocannabinol;Expert Opinion on Drug Metabolism & Toxicology;2024-02

3. Management of monogenic diabetes in pregnancy: A narrative review;World Journal of Diabetes;2024-01-15

4. Diabetes in Pregnancy;Textbook of Diabetes;2024-01-12

5. Successful Prediction of Fetal Exposure to Dual BCRP/P‐gp Drug Substrates Using the Efflux Ratio‐Relative Expression Factor Approach and PBPK M&S;Clinical Pharmacology & Therapeutics;2024-01-08